CIK 0000943819
- Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980152841
- Phone
- +1 858-746-2400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $224.31 | $224K | 83,495 |
| 2026-03-02 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $254.30 | $254K | 84,495 |
| 2026-02-02 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $257.03 | $257K | 85,495 |
| 2026-01-02 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $241.75 | $242K | 86,495 |
| 2025-12-01 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $244.16 | $244K | 87,495 |
| 2025-11-20 | Sandercock Brett Chief Financial Officer | Grant or award | +2,710 | 88,495 | ||
| 2025-11-03 | Sandercock Brett Chief Financial Officer | Option exercise 10b5-1 | +2,000 | $101.64 | $203K | 88,745 |
| 2025-11-03 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −3,000 | $247.54 | $743K | 85,745 |
| 2025-11-03 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −2,000 | 0 | ||
| 2025-10-01 | Sandercock Brett Chief Financial Officer | Option exercise 10b5-1 | +2,000 | $101.64 | $203K | 89,745 |
| 2025-10-01 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −3,000 | $274.36 | $823K | 86,745 |
| 2025-10-01 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −2,000 | 2,000 | ||
| 2025-09-02 | Sandercock Brett Chief Financial Officer | Option exercise 10b5-1 | +2,000 | $101.64 | $203K | 90,745 |
| 2025-09-02 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −3,000 | $270.77 | $812K | 87,745 |
| 2025-09-02 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −2,000 | 4,000 | ||
| 2025-08-15 | Sandercock Brett Chief Financial Officer | Grant or award | +5,462 | 88,745 | ||
| 2025-08-01 | Sandercock Brett Chief Financial Officer | Option exercise 10b5-1 | +2,000 | $101.64 | $203K | 86,283 |
| 2025-08-01 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −3,000 | $281.90 | $846K | 83,283 |
| 2025-08-01 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −2,000 | 6,000 | ||
| 2025-07-01 | Sandercock Brett Chief Financial Officer | Option exercise 10b5-1 | +1,966 | $101.64 | $200K | 87,249 |
Page 1 of 4 · 64 trades